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Pasteurella multocida is responsible for economically important diseases 
in sheep and pigs. Antimicrobial susceptibility studies are essential for initiating 
rational and effective empirical therapy of P. multocida infections. In this study 
we investigated the antimicrobial susceptibility to 18 antimicrobial agents of 156 
clinical isolates of P. multocida from sheep (n = 87) and pigs (n = 69) using the 
microdilution method. Both sheep and pig isolates exhibited low levels of re-
sistance (≤ 15%) to ceftiofur, gentamicin, neomycin, spectinomycin, chlortetracy-
cline, tulathromycin, florfenicol, danofloxacin, and enrofloxacin and trime-
thoprim/sulphamethoxazole, high resistance rates (> 15% up to 50%) to oxytetra-
cycline, tilmicosin, and tiamulin, and very high resistance rates (> 50%) to tylosin 
tartrate, clindamycin, and sulphadimethoxine. However, sheep isolates exhibited 
significantly lower percentages of resistance and lower MIC90 values (P < 0.05) 
than pig isolates for most of the antimicrobials tested. In addition, sheep isolates 
exhibited also significantly lower phenotypic antimicrobial resistance diversity 
(8 resistotypes vs. 30 resistotypes). LAC-LIN-SUL-MAC was the resistotype 
most frequently detected in sheep (39.1%) and LIN-SUL-MAC in pig isolates 
(26.1%). The differences in susceptibility patterns could be influenced by the 
lower use of antimicrobials in the small ruminant industry compared with the pig 
farming industry. 
Key words: Antimicrobial resistance, Pasteurella multocida, pigs, sheep, 
production system  
Pasteurella multocida is an important pathogen responsible for a diversity 
of diseases with an economic impact in different livestock species, including 
sheep and pigs. (Wilson and Ho, 2013). Although this pathogen is usually sus-
ceptible to several antimicrobials, resistance in different animals has been report-
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ed (San Millan et al., 2009; Tang et al., 2009), which represents a threat regard-
ing treatment options. Therefore, monitoring antimicrobial susceptibility is es-
sential to acquire regional information and help veterinarians to initiate rational 
and effective empirical therapy in acute situations. Antimicrobial susceptibility 
studies in P. multocida have mainly been performed in isolates from cattle, poul-
try, or pigs (Post et al., 1991; Lizarazo et al., 2006; Kumar et al., 2009; Furian et 
al., 2016). However, similar studies including isolates from sheep are scarce 
(Berge et al., 2006; Sarangi et al., 2015; Cucco et al., 2017). In Spain, infor-
mation on the antimicrobial susceptibility of porcine P. multocida isolates has 
been reported (Lizarazo et al., 2006), but no similar studies have been conducted 
in sheep. Thus, the aim of this study was to assess the antimicrobial susceptibil-
ity of clinical P. multocida isolates from sheep and pigs, providing information 
on their antimicrobial resistance patterns. This study provides the first data about 
the antimicrobial susceptibility of ovine P. multocida isolates in Spain.  
One hundred and fifty-six P. multocida isolates obtained between 2001 
and 2009 from sheep (n = 87) and pigs (n = 69) were included in this study. All 
porcine isolates were recovered from clinical cases of pneumonia, septicaemia, 
and arthritis, and most of the ovine isolates from cases of pneumonia (García-
Alvarez et al., 2017). Bacteria were isolated from samples on Columbia blood 
agar plates (bioMérieux) incubated at 37 °C for 24 h. Isolates were biochemical-
ly identified by the commercial identification system API 20E strips (bioMé-
rieux, S.A.) and further confirmed by a species-specific PCR assay (Townsend et 
al., 1998). Capsular types and sequence types (STs) were determined previously 
(García-Alvarez et al., 2017). 
Antimicrobial susceptibility was determined by the microdilution method 
using a commercially prepared, dehydrated 96-well microtitre MIC panel 
(BOPO6F, Sensititre; Trek Diagnostic Systems Inc., UK). The antimicrobial 
agents used and their respective dilution ranges are indicated in Tables 1 and 2. 
Inocula were prepared from a 24-h Columbia blood agar plate by suspending 
four colonies in 5 mL of sterile distilled water. The inoculum was adjusted to 0.5 
McFarland standard and further diluted 1/100 in 10 mL of Muller-Hinton broth. 
Fifty microlitres of the adjusted inoculum was deposited in each well of the mi-
croplate panel. Microdilution panels were sealed and further incubated at 37 °C 
for 24 h. The breakpoints used are shown in Tables 1 and 2. Staphylococcus au-
reus ATCC 29213 and Escherichia coli ATCC 25922 were included as quality 
controls with each batch of organisms tested. In this study, resistance rates were 
classified into three categories: low rates, percentage of resistant strains < 15%; 
high rates, 15–50%; and very high rates, > 50%. Multidrug-resistance (MDR) 
was defined as acquired non-susceptibility to at least one agent in three or more 
antimicrobial categories. For the purpose of this study, a bacterial isolate was 
considered resistant to an antimicrobial category when it was resistant to at least 
one agent in that category. The association between the host origin, clinical 
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origin, capsular type or sequence type of P. multocida isolates and antimicrobial 
susceptibility was determined using the Chi-square test, with P < 0.05 considered 
significant. Data were analysed using the Epi InfoTM 7 program of the Centers 
for Disease Control and Prevention (CDC). 
Antimicrobial resistance data of P. multocida have been commonly gener-
ated using different methodologies and different antimicrobials as well as using 
different breakpoints, which can hamper comparison of our results. Despite these 
drawbacks and using the breakpoints indicated in Tables 1 and 2, we detected in 
both sheep and pig isolates low levels of resistance to CEF, GEN, NEO, SPE, 
CTET, TUL, FFN, DANO, ENRO and SxT (≤ 15%; Tables 1 and 2, Fig. 1), 
which agrees with most previous reports both for pig (Yoshimura et al., 2001; 
Tang et al., 2009; Sellyei et al., 2009; Nedbalcová and Kučerová, 2013; Dayao et 
al., 2014; de Jong et al., 2014; El Garch et al., 2016; Cucco et al., 2017) and 
sheep isolates (Sarangi et al., 2015; Cucco et al., 2017). On the other hand, high 
resistance rates (> 15–50%) to OXY, TIL and TIA and very high resistance rates 
(> 50%) to TYLT, CLI, and SDM were identified (Tables 1 and 2, Fig. 1). Over-
all, similar high or very high levels of resistance to these antimicrobials have also 
been reported previously (Lizarazo et al., 2006; Tang et al., 2009; Nedbalcová 
and Kučerová, 2013; de Jong et al., 2014; Tahamtan and Hayati, 2014; El Garch 
et al., 2016; Cucco et al., 2017). Based on these high levels in the resistance in 
vitro, these antimicrobials should not be used empirically to treat P. multocida 
infections or be used with caution under field conditions. Of special concern are 
the very high levels of resistance to TYLT and SDM found in this study both in 
pig and sheep isolates, as these antimicrobials are considered critically important 
and highly important, respectively, for human medicine (World Health Organiza-
tion, 2019). 
It was unexpected that all strains of P. multocida from sheep were re-
sistant to ampicillin (Table 1), compared with the low level of resistance (1.2%) 
detected for penicillin. As no CLSI-defined breakpoints for ampicillin are availa-
ble for ovine P. multocida isolates, in this study we used the breakpoint recom-
mended in the Clinical and Laboratory Standard Institute Vet08 guideline for cat-
tle isolates (CLSI, 2018; ≥ 0.25 µg/ml) which is much higher than that recom-
mended for swine isolates (≥ 2 µg/ml). Similarly, using the breakpoint recom-
mended by the European Committee on Antimicrobial Susceptibility Testing for 
P. multocida (EUCAST, 2019; ≥ 1 µg/ml), all sheep isolates would have been 
considered susceptible. Therefore, the high percentage of resistance to ampicillin 
among sheep isolates is likely biased and overestimated by the breakpoint used 
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The resistotypes identified in this study and their distribution among sheep 
and pig isolates are shown in Table 3. None of the ovine or porcine P. multocida 
isolates was susceptible to the nine antimicrobial categories tested, with the resis-
totype LAC-LIN-SUL-MAC being the most frequently detected among sheep 
isolates (39.1%) and the resistotype LIN-SUL-MAC among pig isolates (26.1%; 
Table 3). No statistically significant differences were detected between percent-
ages of sheep and pig MDR isolates (97.7% vs. 92.8%) but sheep isolates exhib-
ited lower phenotypic antimicrobial resistance diversity (8 resistotypes vs. 30 re-
sistotypes) than pig isolates (Table 3). More than half (55.8%) of the P. multo-
cida isolates of this study were genetically characterised by MLST by García-
Alvarez et al. (2017), with most of the ovine and porcine isolates belonging to a 
limited number of sequence types (ST50 and ST19 among ovine isolates and 
ST3, ST11 and ST62 among porcine isolates). A comparison of the antimicrobial 
resistance patterns and STs of the isolates included in both studies did not detect 
any association between resistance patterns and prevalent genotypes (P > 0.05; 
data not shown). Therefore, unlike in other pathogens (Klugman, 2003; Durante-
Mangoni and Zarrilli, 2011; Edelstein et al., 2013), the differences in the antimi-
crobial resistance between sheep and pig isolates should not be related to the 
presence of particular resistant genotypes within the population of P. multocida. 
Moreover, capsular types A and D were the most frequent in P. multocida iso-
lates in both animal species as determined previously (García-Alvarez et al., 
2017). No associations were identified between resistance patterns of P. multo-
cida with capsular types or with the clinical origin of the isolates (data not 
shown).  
Sheep isolates exhibited significantly lower percentages of resistance (P < 
0.05) than pig isolates for 12 antimicrobials (Tables 1 and 2, Fig. 1). Moreover, 
the MIC90 values for most antimicrobials were also lower in sheep than in pig 
isolates (Tables 1 and 2). The differences in the level of antimicrobial suscepti-
bility between sheep and pig isolates could be associated with the different 
amount of antimicrobials used in the two farming sectors. In fact, pig farming is 
one of the livestock activities with the highest antimicrobial use (Moreno, 2014), 
while the use of antimicrobials is minimal in the small ruminant industry 
(Santman-Berends et al., 2014). Therefore, the higher resistance rates observed 
among pig isolates might reflect the selective pressure related to the higher use of 
antimicrobials in pig farming, at least for some antimicrobials. 
Furthermore, the resistance rates and MIC90 values observed in this study 
among porcine P. multocida isolates for most antimicrobials were higher than 
those observed in a similar study carried out in Spain (Lizarazo et al., 2006), 
suggesting a shift in the resistance to these antimicrobials in Spanish P. multo-
cida isolates from pigs. These results point out the need for active surveillance 
programmes to monitor the antimicrobial resistance patterns of P. multocida. 
 
496 CID et al. 
Acta Veterinaria Hungarica 67, 2019 
Table 3 
Resistance phenotypes (resistotypes) of Pasteurella multocida isolates according to host species 
Resistance to 
Ovine Porcine Total 
n % n % n % 
LAC-LIN 2 2.3   2 1.3 
LAC-SUL   3 4.3 3 1.9 
LIN-MAC   2 2.9 2 1.3 
LAC-LIN-MAC 15 17.2 1 1.4 16 10.3 
LAC-LIN-PLE   1 1.4 1 0.6 
LAC-SUL-MAC 1 1.1   1 0.6 
LIN-SUL-MAC   18 26.1 18 11.5 
LIN-MAC-TET   2 2.9 2 1.3 
SUL-MAC-ANF   1 1.4 1 0.6 
SUL-MAC-AMI   1 1.4 1 0.6 
MAC-PLE-TET   1 1.4 1 0.6 
LAC-LIN-MAC-TET   1 1.4 1 0.6 
LAC-LIN-MAC-PLE 5 5.7   5 3.2 
LAC-LIN-SUL-MAC 34 39.1 6 8.7 40 25.6 
LAC-SUL-MAC-TET   3 4.3 3 1.9 
LIN-SUL-MAC-PLE   4 5.8 4 2.6 
LIN-SUL-MAC-TET   3 4.3 3 1.9 
SUL-MAC-TET-AMI   1 1.4 1 0.6 
SUL-MAC-TET-QUIN   1 1.4 1 0.6 
LIN-MAC-SUL-TET   2 2.9 2 1.3 
LIN-SUL-MAC-AMI   4 5.8 4 2.6 
LAC-LIN-SUL-MAC-TET 11 12.6 2 2.9 13 8.3 
LAC-LIN-SUL-MAC-AMI   1 1.4 1 0.6 
LAC-LIN-SUL-MAC-PLE 16 18.4 1 1.4 17 10.9 
LIN-MAC-PLE-TET-AMI   1 1.4 1 0.6 
LIN-MAC-SUL-PLE-TET   1 1.4 1 0.6 
LAC-LIN-SUL-MAC-AMI-QUIN   1 1.4 1 0.6 
LAC-LIN-SUL-MAC-TET-AMI   1 1.4 1 0.6 
LAC-LIN-SUL-MAC-PLE-TET 3 3.4 1 1.4 4 2.6 
LIN-SUL-MAC-TET-AMI-QUIN   1 1.4 1 0.6 
LAC-SUL-MAC-PLE-TET-ANF-AMI   1 1.4 1 0.6 
LAC-LIN-SUL-MAC-PLE-TET-ANF-AMI   1 1.4 1 0.6 
LAC-LIN-SUL-MAC-PLE-TET-ANF-AMI-QUIN   2 2.9 2 1.3 
Total 87 100.0 69 100.0 156 100.0 
Abbreviations: LIN: lincosamides; SUL: sulphonamides; MAC: macrolides; TET: tetracyclines; 
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